Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer

Por Pizon, M, Zimon, D, Carl, S, Pachmann, U, Pachmann, K, Camara, O
Publicado em 2013

Efficacy control of therapy using circulating epithelial tumor cells (CETC) as “Liquid Biopsy”: trastuzumab in HER2/neu-positive breast carcinoma

Por Pachmann, Katharina, Camara, O., Kroll, T., Gajda, M., Gellner, A. K., Wotschadlo, J., Runnebaum, I. B.
Publicado em 2011

Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive...

Por Gajda, M., Camara, O., Oppel, S., Kroll, T., Jörke, C., Krauspe, S., Hammer, U., Rabenstein, C., Untch, M., Runnebaum, I. B., Pachmann, K.
Publicado em 2008